BioSpace News Archive

SpyGlass Pharma™ announced the appointments of Margot Goodkin, M.D., Ph.D., as Chief Medical Officer and Bilal Khan, MBA, to the SpyGlass Board of Directors.

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the initiation of patient enrollment in the Phase 2a biomarker study evaluating GRI-0621 for the treatment of IPF.

Regen BioPharma, Inc. will be presenting at the Emerging Growth Conference on December 7, 2023.

CytoMed Therapeutics Limited today announced that it has entered into a Heads of Agreement (HOA) with CytoMed Therapeutics China Limited company incorporated in Hong Kong and a Memorandum of Understanding (MOU) with BioNex Solutions Inc.

The Barbara Ann Karmanos Cancer Institute has appointed Doris Ranski-Zazula, RN , MSA, as the vice president of the Karmanos Cancer Network, part of McLaren Health Care.

Quipt Home Medical Corp. will announce its fourth quarter and full year 2023 financial results on Monday, December 18, 2023.

Annovis Bio, Inc. today announced last patient last visit in the phase III study of its lead candidate buntanetap in patients with early Parkinson’s disease (PD).

Adaptive Biotechnologies Corporation together with its collaborators will present data at the 65th Annual Meeting of the American Society of Hematology (ASH), December 9-12 in San Diego, California.

Accuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided radiation therapy (SGRT) on the Radixact ® System in Japan beginning November 30, 2023.

Eli Lilly and Company (NYSE: LLY) today announced that Zepbound™ (tirzepatide) injection is now available.